Publication: Brief report: PAX4 mutations in Thais with maturity onset diabetes of the young
2
Issued Date
2007-01-01
Resource Type
ISSN
0021972X
0021972X
0021972X
Other identifier(s)
2-s2.0-34447132254
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Clinical Endocrinology and Metabolism. Vol.92, No.7 (2007), 2821-2826
Suggested Citation
Nattachet Plengvidhya, Suwattanee Kooptiwut, Napat Songtawee, Asako Doi, Hiroto Furuta, Masahiro Nishi, Kishio Nanjo, Wiwit Tantibhedhyangkul, Watip Boonyasrisawat, Pa Thai Yenchitsomanus, Alessandro Doria, Napatawn Banchuin Brief report: PAX4 mutations in Thais with maturity onset diabetes of the young. Journal of Clinical Endocrinology and Metabolism. Vol.92, No.7 (2007), 2821-2826. doi:10.1210/jc.2006-1927 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/24289
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Brief report: PAX4 mutations in Thais with maturity onset diabetes of the young
Other Contributor(s)
Abstract
Context: Six maturity onset diabetes of the young (MODY) genes have been discovered to date but account for a small proportion of MODY among Asians, suggesting the existence of other MODY genes in this racial group. Objective: The aim of this study was to investigate whether or not genetic variants in PAX4, a crucial transcription factor in β-cell development, contribute to MODY in Thais. Design and Methods: We screened PAX4 coding sequences in 46 MODY probands without mutation in known MODY genes and in 74 nondiabetic controls using PCR-single-stranded conformational polymorphism analysis followed by direct sequencing. Genotyping of variants identified was done by PCR-restriction fragment length polymorphism analysis. Results: Eight sequence differences were identified. Two novel variations (R164W and IVS7-1G>A) were found in two different probands. Neither was found in the 74 nondiabetic controls and additional 270 healthy subjects of Thai origin. R164W segregated with diabetes in the family of the proband and in vitro studies showed that it impairs the repressor activity of PAX4 on the insulin and glucagon promoters. The remaining six variants were previously described and observed in both groups. One of them, R192H, was three times more frequent in MODY probands than in 342 nondiabetic controls (minor allele frequency = 0.196 vs. 0.064; P < 0.00001). The same variant was associated with a younger age at diagnosis among 254 Thai subjects with adult-onset type 2 diabetes (44.6 ± 15 vs. 49.7 ± 11 yr; P = 0.048). Conclusions: We have identified two possible pathogenic mutations of PAX4, R164W, and IVS7-1G>A. For one of these, we have shown evidence of segregation with diabetes and a functional impact on PAX4 activity. Single-nucleotide polymorphism R192H might influence the age at onset of diabetes. Copyright © 2007 by The Endocrine Society.